Zagreb, Croatia

Mirela E Skinja

This inventor holds 1 USPTO granted patent. Top assignee: Pliva, Farmaceutska, Kemijska, Prehrambena I Kozmeticka Industrija,. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mirela E Skinja: Innovator in Hypoglycemic Activity

Introduction

Mirela E Skinja is a prominent inventor based in Zagreb, Croatia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with hypoglycemic activity. Her innovative work has led to the creation of a unique patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Mirela holds a patent for "Hydroxylamines with hypoglycemic activity." This patent involves the preparation of novel 1-(2-,3- or 4-hydroxylaminobenzensulfonyl-1a,2,6,6 a-tetrahydro-1H,4H-[1,3]-dioxepino[5,6-b]azirines with hypoglycemic activity through the selective reduction of appropriate 1-(2-,3- or 4-nitrobenzenesulfonyl) derivatives. This innovative approach has the potential to impact the treatment of diabetes and related conditions.

Career Highlights

Mirela is associated with Pliva, a leading pharmaceutical, chemical, food, and cosmetic industry company. Her role at Pliva has allowed her to collaborate with other talented professionals in the field, further enhancing her contributions to pharmaceutical research and development.

Collaborations

Mirela has worked alongside notable colleagues, including Miljenko Dumić and Darko Filić. Their collaborative efforts have fostered an environment of innovation and creativity, leading to advancements in their respective fields.

Conclusion

Mirela E Skinja is a remarkable inventor whose work in hypoglycemic activity has the potential to make a significant impact in the medical field. Her dedication to innovation and collaboration exemplifies the spirit of advancement in pharmaceutical research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…